KIDSORTHOPEDIATRICS CORP

Nasdaq orthopediatrics.com


$ 30.60 $ -0.07 (-0.23 %)    

Monday, 09-Sep-2024 15:59:44 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 30.59
$ 30.98
$ 30.56 x 200
-- x --
$ 30.05 - $ 31.38
$ 23.10 - $ 36.23
146,987
na
740.72M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-08-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-01-2023 06-30-2023 10-Q
6 05-02-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-03-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-11-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 03-05-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-07-2019 12-31-2018 10-K
24 10-31-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-15-2018 12-31-2017 10-K
28 11-13-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-buy-on-orthopediatrics-maintains-42-price-target

Needham analyst Mike Matson reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $42 price target.

 truist-securities-reiterates-hold-on-orthopediatrics-lowers-price-target-to-30

Truist Securities analyst Richard Newitter reiterates OrthoPediatrics (NASDAQ:KIDS) with a Hold and lowers the price target ...

 orthopediatrics-q2-2024-adj-eps-023-beats-027-estimate-sales-52802m-beat-52495m-estimate

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.2...

 truist-securities-maintains-hold-on-orthopediatrics-lowers-price-target-to-35

Truist Securities analyst Samuel Brodovsky maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and lowers the price target f...

 truist-securities-maintains-hold-on-orthopediatrics-raises-price-target-to-38

Truist Securities analyst Samuel Brodovsky maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target f...

 needham-maintains-buy-on-orthopediatrics-raises-price-target-to-42

Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $37 to $42.

 jmp-securities-reiterates-market-outperform-on-orthopediatrics-maintains-50-price-target

JMP Securities analyst David Turkaly reiterates OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and maintains $50 pri...

 orthopediatrics-q1-2024-adj-eps-030-beats-040-estimate-sales-44685m-beat-41775m-estimate

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.4...

 orthopediatrics-corp-receives-breakthrough-device-designation-from-fda-for-elli-growing-rod-system-for-pediatric-patients-with-scoliosis

OrthoPediatrics Corp. ("OrthoPediatrics") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediat...

 needham-reiterates-buy-on-orthopediatrics-maintains-37-price-target

Needham analyst Mike Matson reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $37 price target.

 truist-securities-maintains-hold-on-orthopediatrics-raises-price-target-to-32

Truist Securities analyst Samuel Brodovsky maintains OrthoPediatrics (NASDAQ:KIDS) with a Hold and raises the price target f...

 stifel-maintains-buy-on-orthopediatrics-raises-price-target-to-34

Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $32 to $34.

 needham-reiterates-buy-on-orthopediatrics-maintains-37-price-target

Needham analyst Mike Matson reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $37 price target.

 american-eagle-reports-upbeat-earnings-joins-kroger-burlington-stores-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday.

 jmp-securities-reiterates-market-outperform-on-orthopediatrics-maintains-50-price-target

JMP Securities analyst David Turkaly reiterates OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and maintains $50 pri...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION